Category: Research
Research Methods of developing new anticancer drugs ...
Category: Research
... with loss of PPP2R2A are highly sensitive to two specific classes of anticancer drugs: 1) PARP inhibitors - these are a class of drugs currently in clinical trials for a range of cancers. We believe ...
Category: Research
... with loss of PPP2R2A are highly sensitive to two specific classes of anticancer drugs: PARP inhibitors, and PP2A activating drugs. This project will test whether tumours with PPP2R2A loss will ...
Category: Research
Fluoropyrimidines (5-FU and capecitabine) are anticancer drugs commonly used in a range of cancers including oesophageal, gastric ...
Category: Research
... In 2014, researchers reported a new combination of anti-cancer drugs and radiation which was successful in treating men with ...